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Zinc finger proteins constitute a major group of
transcription factor and play important roles in the gene
expression at the terminus of cellular signal transduction.  Our
interest has been focused on a C2H2 type zinc finger protein
HIV-EP1 which binds to DNA kB site (5'-GGGACTTTCC-
3') present in the long terminal repeat of HIV provirus to
activate the HIV-1 gene expression.  Inhibition of HIV-EP1
would lead to the interference of the replication of AIDS
virus.  In the previous ICR Annual Report, we described a
new strategy for the inhibition of zinc finger proteins, i. e.
removal of zinc from the finger domain by use of chelator.
Thus, heterocyclic ligands comprising a dimethylaminopyridine
and histidine units such as 1 exhibited remarkable zinc-binding
capability and showed marked inhibitory effect on the DNA
binding activity of HIV-EP1.
We now intended to replace the imidazole in the inhibitor
1 by mercapto group since mercapto group is contained in all
known zinc finger proteins as a key ligating residue.  It was
considered that replacement of the imidazole moiety of our
previous synthetic chelators by a mercapto group would alter
the fundament of the metal binding characteristics and hence
we prepared novel chelators 2 and 3 and some related sulfur-
containing ligands.
Compounds 2 and 3 were found to be easily autoxidized
under basic condition, resulting in the formation of disulfides
whose main constituents were those assignable to 11 and 12.
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HIV-EP1 is a C2H2 type zinc finger protein which binds to DNA kB site present in the long terminal repeat
of HIV provirus.  Previously we have reported zinc chelators having histidine-pyridine-histidine skeleton
and were successful to inhibit the DNA binding of HIV-EP1 by removing zinc from the zinc finger domain.
Aiming at the potentiation of the inhibitory activity, we synthesized novel chelators comprising pyridine and
aminoalkylthiol.  These showed marked inhibitory activity on the DNA binding of HIV-EP1.  In particular,
one of them having bis(2-mercaptoethyl)amino side chain showed inhibitory activity (IC50, ~4m M), 10 times





The major goal of our laboratory is to elucidate the molecular basis of the activity of various bioactive substances
by biochemical, physicochemical, and synthetic approaches.  These include studies on the mechanism of sequence-
specific DNA cleavage by antitumor or carcinogenic molecules, probing the DNA fine structure by various
chemicals, studies on the DNA recognition of zinc-finger proteins, construction of artificial restriction enzyme, and
model study on the cooperative mechanism of DNA binding by dimeric peptides.  Also studied are the design and
synthesis of functional molecules that effectively regulate the intracellular signal transduction or that applicable
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We found disulfides 9 ¾ 12 to be stable in air, easy to handle,
and quantitatively reducible by dithiothreitol to generate either
2 or 3 in situ.  Therefore, we employed 9¾ 12 as practical
equivalents for 2 and 3 in the biochemical experiments
described below.
The inhibitory effects of imidazole compound 1, mercapto
compounds 2, 3, and alkylthio compounds 4¾ 8 on the DNA
binding of HIV-EP1 were studied by electrophoretic mobility
shift assay.  Compound 2 or 3 generated from 9 or 10 was
indistinguishable from that obtained from 11 or 12 in terms of
the inhibitory activity.  Mercapto compounds 2 and 3
exhibited remarkable inhibitory effect much stronger than that
of imidazole compound 1.  The most potent was compound 2,
which inhibited DNA binding of HIV-EP1 almost completely
at 30 m M concentration, whereas 300 m M of 1 was required
for the effective inhibition.  IC50 of 2 was ~4 m M.  Thus,
inhibitory activity of compound 2 was shown to be 10 times
stronger than that of 1.  tert-Butylthio, trirylthio, and
methylthio analogues  4 ¾ 8, and other thiols, e. g. 2-
aminoethanethiol, glutathione, and dithiothreitol, showed
markedly lowered inhibitory effect at 30 m M concentration.  It
should be noted that inhibitory effect of 2-aminoethanethiol
was small but significant because this constitutes the side
chain of the inhibitor 2, demonstrating the effect of
assembling the 2-aminoethanethiol units on a pyridine ring in
potentiating the inhibitory activity.
As previously reported, compound 1 was shown to
abstract zinc from the zinc finger site of HIV-EP1 because the
DNA-HIV-EP1 binding was restored by the addition of zinc
before or after the inhibition reaction.  In contrast, when zinc
was introduced after the DNA binding inhibition reaction with
2 or 3, virtually no or limited recovery of HIV-EP1-DNA
complex was observed.  This mechanism of the inhibition,
seemingly distinct from that of our previous inhibitors, could
be a new clue to the specificity issue to distinguish zinc finger
proteins, which is our next subgoal.
References
1. Otsuka M, Fujita M, Sugiura Y, Ishii S, Aoki T,
Yamamoto T, Inoue J, J. Med. Chem., 37, 4267-4269
(1994).
2. Otsuka M, Fujita M, Aoki T, Ishii S, Sugiura Y,
Yamamoto T, Inoue J, J. Med. Chem., 38, 3264-3270
(1995).
3. Fujita M, Otsuka M, Sugiura Y, J. Med. Chem., 39,
503-507 (1996).
ICR Annual Report, Vol. 3, 1996 41
